BREAKING NEWS Urgent recall for popular juice brand in 28 states over potentially deadly mold in containers
A recall for more than 170,000 bottles of a popular brand of apple juice has been issued in 28 states over fears that bottles may be contaminated with deadly fungi.
The product impacted is Martinelli Apple Juice sold in its signature clear, round glass bottles with a white metal screw top lid.
The recalled 10-ounce bottles were sold in four-packs with the product number '0 41244 04102 2' and a best-by date of December 5, 2026.
The information is printed on the label or on the bottle itself.
The Food and Drug Administration (FDA) initiated the voluntary recall over possible contamination of patulin, a naturally occurring toxic substances produced by molds.
This is a developing story... More updates to come
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medical News Today
4 hours ago
- Medical News Today
How Tremfya works: Mechanism of action explained
How it works How long it takes to work Tremfya (guselkumab) is a prescription drug that treats psoriatic arthritis, plaque psoriasis, and ulcerative colitis. Its mechanism of action is binding to interleukin-23 that's overactive. Tremfya belongs to a class of medications called interleukin-23 blockers. It's a type of biologic called a monoclonal antibody, which is a protein that attaches to substances in the body. Tremfya works by binding to interleukin-23 (a protein in the body) that's overactive. By binding to this protein, Tremfya decreases how active your immune system is to ease inflammation and decrease symptoms of your condition. The way a drug works is known medically as its mechanism of action. The mechanism of action for Tremfya may vary depending on the condition it's being used to treat. Tremfya is approved by the Food and Drug Administration (FDA) to treat certain conditions, including psoriatic arthritis. When you have psoriatic arthritis, your immune system (your body's defense against infections) is overactive. It attacks healthy tissues and cells, causing joint pain and inflammation. It also causes your body to make too many skin cells, leading to a buildup of cells and areas called plaques. These plaques are flushed, itchy patches on your skin. Tremfya is FDA-approved to treat moderate to severe plaque psoriasis. This condition is one of many types of psoriasis. When you have plaque psoriasis, your immune system is overactive. It causes your body to make too many skin cells, leading to a buildup of cells and areas called plaques. These plaques are itchy patches on your skin. They may look pink or be darker than your skin color. Sometimes, they may look white and scaly. Tremfya may be an option for plaque psoriasis treatment if you can receive either: systemic therapy (treatment that affects your whole body), or phototherapy (treatment with light) Tremfya is FDA approved to treat moderate to severely active ulcerative colitis (UC) in adults. When UC is active, it's causing symptoms. Tremfya is prescribed to help put UC in remission and keep it there. With remission, you have few or no symptoms of the condition. Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. It's thought to result from overactivity in a person's immune system. With UC, you have inflammation in your colon, rectum, or both. In severe cases, ulcers can also form in these areas. Symptoms of this condition include blood in your stool, diarrhea, abdominal pain or cramps, and weight loss. For this condition, Tremfya is typically prescribed alone. Your doctor may also prescribe nonbiologics to treat an ulcerative colitis flare-up. Tremfya is FDA approved to treat Crohn's disease. Like UC, Crohn's disease is a type of IBD. Unlike UC, which affects the colon and rectum, Crohn's disease can affect your entire digestive system, including your stomach, intestines, and colon. To find out more about Crohn's disease, visit our IBD hub. In clinical trials, people with plaque psoriasis often experienced a reduction in symptoms after receiving three doses of Tremfya over 16 weeks. Also, more than half of the people receiving Tremfya for psoriatic arthritis in clinical trials experienced a decrease in symptoms after 16 weeks of treatment. In a clinical trial of Tremfya for UC, more than half of the people receiving the drug experienced a decrease in symptoms after 12 weeks. Some people also experienced remission (few or no symptoms of UC). If you have more questions about how long it takes for Tremfya to work, talk with your doctor or pharmacist. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
Metro
6 hours ago
- Metro
Popular US remedy recalled over ‘life-threatening fungi' with kids most at risk
Nasal and baby teething swabs sold across the US have been recalled over fears of contamination with fungi. Church & Dwight Co, Inc, announced on Friday it is recalling its Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs and Orajel Baby Teething Swabs on Friday 'due to potential microbial contamination identified as fungi in cotton swab components'. The swabs that are contaminated 'can potentially present a significant risk to the health and safety of consumers including serious and life-threatening blood infections in users whose nasal mucosa may be compromised due to inflammation and mechanical injuries', stated the announcement shared by the country's agency protecting public health. All lots of the three products are under the recall. Zicam Cold Remedy Nasal Swabs, designed to shorten the common cold, have the UPC number 732216301205. Zicam Nasal AllClear Swabs, meant for cleansing, were discontinued in December 2024 and have the UPC number 732216301656. Orajel Baby Teething Swabs, designed to soothe discomfort from teething, have the UPC number 310310400002. They were distributed nationwide and in Puerto Rico. Customers should stop using the swabs immediately and contact the company for a full refund. More Trending There have not been any reports of illness from the swabs, but any concerns should be flagged to the US Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program. 'The risk is highest (potentially severe or life-threatening) among children and individuals with compromised immune systems or other underlying medical conditions,' stated the notice from the FDA. Church & Dwight describes itself as a $4.9billion 'leading manufacturer of consumer household and personal care products' based in Ewing, New Jersey. It comes a few months after Ascent Consumer Products Inc recalled a lot of its SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System nationwide due to tests confirming microbial contamination with Staphylococcus aureus (S. aureus). That bacteria can also cause users with nasal mucosa inflammation or injuries to have blood infections. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Costco and Amazon fitness product sold almost 4,000,000 times recalled over broken bones MORE: Mums 'in love triangle' fought in school playground in front of children MORE: Popular clothing retailer to close almost 200 more stores in 2025
Daily Mail
8 hours ago
- Daily Mail
Urgent nationwide recall for OTC cold meds amid fears they could cause fatal fungal BRAIN infections
Officials have issued a recall for multiple cold remedy nasal swabs over fears of a fungi contamination that can cause deadly infections. The Food and Drug Administration has asked consumers to stop using Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs and Orajel Baby Teething Swabs immediately. According to manufacturer Church & Dwight Co., the cotton swab parts of each individual product may have a 'potential microbial contamination identified as fungi'. Officials warn that if used, the possible fungi contamination can cause serious and life-threatening blood infections in patients. The federal agency also noted that children and adults with compromised immune systems or other underlying medical conditions were at the highest risk of developing a fatal infection. Because the swabs are insert deep in the nose, there is a risk the infection could travel to the brain. While it remains unclear which fungi has been found in the products, they can enter the body through contaminated medical products such as swabs, surgical procedures or simply through air and cause blood infections. The FDA has asked consumers to throw away both Zicam products with lot numbers 732216301205 and 732216301656 and Orajel products with number 310310400002. The agency has also asked consumers to reach out to the manufacturer for a full refund. As of now, no reports of illness or death have been revealed by the agency. The recalled products were distributed nationwide in the United States and in Puerto Rico. While Zicam Cold Remedy Nasal Swabs and Orajel Baby Teething Swabs continue to be sold and available in pharmacies, Zicam Nasal AllClear Swabs were discontinued in December 2024. Additionally, the FDA assured consumers that all other Zicam and Orajel products, including Zicam RapidMelts are safe to use to cure colds. Both of the recalled Zicam nasal swabs are meant to soothe and shorten the duration of a cold by rubbing the gel-covered cotton part of the swab inside each nostril. According to the company's website, the gel formula covering the swabs contain plant-based active ingredients including Galphimia glauca, Luffa operculata and Sabadilla. Similarly, the Orajel Baby Teething Swabs are used to to help soothe infants who may be teething, upset, cranky or fussy. However in this case, rubbing the contaminated part of swab inside your nostril or inside the mouth may introduce the fungi into your bloodstream and cause an infection. To fight the infection, the immune system releases chemicals into the bloodstream that can cause widespread inflammation in the body. This can lead to sepsis - which can cause damage to tissues, organ failure and death. Treatment for a blood infection typically involves antifungal medications. In a statement, the FDA explained: 'Swabs found to contain microbial contamination can potentially present a significant risk to the health and safety of consumers including serious and life-threatening blood infections in users whose nasal mucosa may be compromised due to inflammation and mechanical injuries.' Typical symptoms of a fungi-caused blood infection include fever, chills, lethargy, and pain. If left untreated, it can lead to organ failure and in certain cases, death. In the US, the most common fungus known to cause bloodstream infections is Candida. About 25,000 Americans suffer from candida blood infections every year.
